Auriga Lowers PT On MedAssets To $19

Auriga has lowered the price target on MedAssets MDAS from $21 to $19 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetAnalyst RatingsAurigaHealth CareHealth Care Technology
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!